HIGHLIGHTS
- who: Shuo Liu from the (UNIVERSITY) have published the research work: A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD, in the Journal: (JOURNAL)
- what: At that time, the study only focused on Alpha and Beta variants, as well as some sites with higher mutation frequency6.
SUMMARY
Mutations in these variants may be located in the binding epitopes of mAbs, or may cause conformational changes in S proteins, resulting in changes in the accessibility of binding epitopes, affecting the neutralization of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.